Breast Cancer Clinical Trial 2017-084CIRB

[LCID Study Number: 2017-084CIRB]

1501: Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer

The purpose of this study is to evaluate Carvedilol in the prevention of cardiac toxicity in patients with Metastatic HER-2+ Breast Cancer.

Disease/Condition: Breast Cancer

Department: Hematology and Oncology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody; Winchester Hospital

Primary Contact Email: cancerclinicaltrials@lahey.org

Primary Contact Phone: 781-744-3421